Back to CRVS

Corvus Pharmaceuticals, Inc. 8-K

Accession 0001171843-23-004019

Filing information

CIK
0001626971
Report date
2023-06-15
Filing date
2023-06-21
Form
8-K
Primary document
f8k_062023.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.